First Choice Healthcare Solutions Announces Third Quarter 2016 Results

November 15, 2016 8:30 AM EST

MELBOURNE, FL -- (Marketwired) -- 11/15/16 -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("FCHS," "First Choice" or the "Company"), one of the nation's only non-physician-owned, publicly traded healthcare services companies focused on the delivery of total musculoskeletal solutions with an emphasis on Orthopaedic and Spine care, today reported its financial results for the three and nine months ended September 30, 2016.

Financial Highlights for the Comparable Nine Month Reporting Periods in 2016 and 2015, respectively:

  • Total revenues up 72% to $22.56 million from $13.12 million
  • Non-GAAP adjusted EBITDA* increased to $3.51 million from $2.62 million
  • Notwithstanding the one-time $9.21 million gain from the sale of Marina Towers and other property and improvements, net income attributable to First Choice totaled $1.05 million, or $0.04 earnings per diluted share, compared to approximately $165,200, or $0.01 earnings per diluted share

Financial Highlights for the Comparable Three Month Reporting Periods in 2016 and 2015, respectively:

  • Total revenues increased 22% to $7.70 million, up from $6.29 million
  • Non-GAAP adjusted EBITDA* totaled $1.45 million, compared to $1.85 million
  • Net income attributable to First Choice totaled approximately $545,000, or $0.02 earnings per diluted share, compared to approximately $631,281, or $0.03 earnings per diluted share

As of September 30, 2016, cash totaled $6.59 million, accounts receivable were $9.48 million and total stockholders' equity attributable to First Choice was $13.41 million. This compared to cash of $1.60 million, restricted cash of $360,000, accounts receivable of $6.62 million and total stockholders' equity attributable to First Choice of $2.12 million as of the end of December 2015.

Chris Romandetti, President and Chief Executive Officer of First Choice, stated, "While we are very pleased with our success in perpetuating revenue growth year-over-year, we are particularly gratified that our strategies to strengthen operating margins on total revenues has also continued to be positively impactful. Moreover, recruitment of new best-in-class physicians to our Space Coast, Florida care delivery platform continues to advance very well. Expansion initiatives being implemented in our ancillary services channels are also moving forward, while our Medical Centers of Excellence continue to sustain and further strengthen our overall profitability. And, given First Choice's strong working capital position, we are well positioned to assess and pursue a broad range of non-dilutive options for capital to finance even more dynamic growth in the future."

"All things considered, we are very pleased with our year-to-date progress. Looking ahead, we intend to persist in executing smart, purpose-driven business-building strategies that will allow us to achieve even more pronounced revenue and earnings growth in the coming year while notably enhancing sustainable long term value for our fellow shareholders," concluded Romandetti.

Public Conference Call & Webcast First Choice's executive management team will host a conference this morning, beginning at 11:00 AM. Participants can register and access the conference call by dialing toll-free 866-682-6100. The conference call will also be webcasted, which can be accessed through First Choice's investor relations website by navigating to http://ir.myfchs.com/ and clicking on "Third Quarter 2016 Conference Call and Webcast." Participants will be required to register to access the call. For those who cannot listen to the live broadcast, a replay will be available shortly after the call on the investor relations page of First Choice's website, found at http://ir.myfchs.com/.

*About Non-GAAP Financial Measures To supplement our consolidated financial statements, which are prepared and presented in accordance with GAAP, we use non-GAAP EBITDA, which is factored by adding back any non-cash or non-recurring gain or expense to the Net Income Attributable to First Choice. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use this non-GAAP financial measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. Our management believes that this non-GAAP financial measure provides meaningful supplemental information regarding our performance and liquidity by excluding certain items that may not be indicative of our recurring core business operating results. We believe that both management and investors benefit from referring to this non-GAAP financial measure in assessing our performance and when planning, forecasting, and analyzing future periods. This non-GAAP financial measure also facilitates management's internal comparisons to our historical performance and liquidity. We believe this non-GAAP financial measure is useful to investors both because they allow for greater transparency with respect to a key metric used by management in its financial and operational decision-making. For more information on this non-GAAP financial measure, please see the table captioned "Reconciliation of Non-GAAP Adjusted EBITDA Performance."

For additional details relating to First Choice's third quarter 2016 results, please refer to the Interim Report on Form 10-Q filed with the U.S. Securities and Exchange Commission and found at www.sec.gov.



                  FIRST CHOICE HEALTHCARE SOLUTIONS, INC.
                   CONDENSED CONSOLIDATED BALANCE SHEETS

                                               September 30,   December 31,
                                                    2016           2015
                                               -------------  -------------
                                                (unaudited)
                    ASSETS
Current assets
Cash (amounts related to VIE of $1,445,090 and
 $1,556,303)                                   $   6,591,035  $   1,594,998
Cash-restricted                                            -        359,414
Accounts receivable, net (amounts related to
 VIE of $5,558,273 and $4,544,308)                 9,477,069      6,623,894
Employee loans (amounts related to VIE of
 $509,350 and $636,293)                              783,009        672,293
Prepaid and other current assets (amounts
 related to VIE of $269,352 and $183,465)            446,721        316,773
Capitalized financing costs, current portion
 (amounts related to VIE of $-0- and $1,317)               -         39,533
                                               -------------  -------------
  Total current assets                            17,297,834      9,606,905
                                               -------------  -------------

Property, plant and equipment, net of
 accumulated depreciation of $1,065,517 and
 $3,075,648 (amounts related to VIE of
 $717,557 and $773,808)                            2,629,309      8,613,502
                                               -------------  -------------

Other assets
Goodwill (amount relating to VIE of $899,465)        899,465        899,465
Deferred costs, net of amortization of
 $457,079 and $215,096                             2,769,348      3,011,331
Patient list, net of accumulated amortization
 of $90,000 and $75,000                              210,000        225,000
Patents, net of accumulated amortization of
 $52,525 and $38,200                                 233,975        248,300
Investments (amounts related to VIE of $22,005
 and $16,914)                                         22,005         16,914
Deferred tax asset                                   181,029              -
Deposits                                               2,571          2,571
                                               -------------  -------------
  Total other assets                               4,318,393      4,403,581
                                               -------------  -------------

Total assets                                   $  24,245,536  $  22,623,988
                                               =============  =============


            LIABILITIES AND EQUITY
Current liabilities
Accounts payable and accrued expenses (amounts
 related to VIE of $1,751,197 and $2,319,056)  $   2,827,742  $   3,937,244
Accounts payable, related party (amount
 related to VIE of $251,588)                         251,588        251,588
Stock-based payable                                  253,991      1,198,900
Advances                                                   -         43,082
AMT tax payable                                      181,029              -
Settlement payable                                         -        600,000
Line of credit, short term (amount related to
 VIE of $439,524 and $416,888)                     2,939,524      2,566,888
Note payable, related party, current portion
 (amount related to VIE of $-0- and $428,645)              -        428,645
Notes payable, current portion (amount related
 to VIE of $1,021 and $10,341)                       517,666      7,652,941
Unearned revenue                                      43,650         42,704
Deferred rent, short term portion (amount
 related to VIE of $237,620 and $118,810)            237,620        118,810
                                               -------------  -------------
  Total current liabilities                        7,252,810     16,840,802
                                               -------------  -------------

Long term debt:
Deposits held                                         41,930         67,432
Notes payable, long term portion                     143,856        535,822
Deferred rent, long term portion (amount
 related to VIE of $2,200,603 and $2,141,199)      2,253,060      2,141,199
                                               -------------  -------------
  Total long term debt                             2,438,846      2,744,453
                                               -------------  -------------

Total liabilities                                  9,691,656     19,585,255
                                               -------------  -------------

Equity
Preferred stock, $0.01 par value; 1,000,000
 shares authorized, Nil issued and outstanding             -              -
Common stock, $0.001 par value; 100,000,000
 shares authorized, 24,238,613 and 22,867,626
 shares issued and outstanding as of September
 30, 2016 and December 31, 2015, respectively         24,239         22,868
Common stock subscription                                  -        175,000
Additional paid-in capital                        22,393,921     21,196,792
Accumulated deficit                               (9,009,899)   (19,274,917)
                                               -------------  -------------
Total stockholders' equity attributable to
 First Choice Healthcare Solutions, Inc.          13,408,261      2,119,743
Non-controlling interest (note 14)                 1,145,619        918,990
                                               -------------  -------------
  Total equity                                    14,553,880      3,038,733
                                               -------------  -------------

Total liabilities and equity                   $  24,245,536  $  22,623,988
                                               =============  =============


                   FIRST CHOICE HEALTHCARE SOLUTIONS, INC
              CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                (unaudited)

                         Three months ended           Nine months ended
                            September 30,               September 30,
                         2016          2015          2016          2015
                     ------------  ------------  ------------  ------------
Revenues:
Patient Service
 Revenue             $  7,403,084  $  5,775,986  $ 21,571,205  $ 11,871,574
Provision for bad
 debts                   (319,319)            -      (849,037)      (51,485)
                     ------------  ------------  ------------  ------------
Net patient service
 revenue less
 provision for bad
 debts                  7,083,765     5,775,986    20,722,168    11,820,089
Rental Revenue            585,978       516,136     1,842,428     1,301,515
                     ------------  ------------  ------------  ------------
 Total Revenue          7,669,743     6,292,122    22,564,596    13,121,604

Operating expenses:
Salaries and
 benefits               3,158,172     2,240,109     9,077,783     5,311,710
Other operating
 expenses               1,405,489       670,923     4,166,139     1,685,830
General and
 administrative         2,404,996     2,234,647     7,346,614     4,437,801
Depreciation and
 amortization             195,821       273,263       631,571       558,189
                     ------------  ------------  ------------  ------------
 Total operating
  expenses              7,164,478     5,418,942    21,222,107    11,993,530
                     ------------  ------------  ------------  ------------

Net income from
 operations               505,265       873,180     1,342,489     1,128,074

Other income
 (expense):
Gain on sale of
 property and
 improvements                   -             -     9,212,346             -
Miscellaneous income
 (expense)                135,544       (18,400)      241,213        22,719
Amortization
 financing costs                -       (20,592)      (15,654)      (60,507)
Interest expense,
 net                      (56,560)     (202,907)     (288,748)     (925,045)
                     ------------  ------------  ------------  ------------
 Total other expense       78,984      (241,899)    9,149,157      (962,833)
                     ------------  ------------  ------------  ------------

Net income before
 provision for
 income taxes             584,249       631,281    10,491,646       165,241

Income taxes
 (benefit)                      -             -             -             -
                     ------------  ------------  ------------  ------------

Net income                584,249       631,281    10,491,646       165,241

Non-controlling
 interest                 (39,309)            -      (226,628)            -
                     ------------  ------------  ------------  ------------

NET INCOME
 ATTRIBUTABLE TO
 FIRST CHOICE
 HEALTHCARE
 SOLUTIONS, INC.     $    544,940  $    631,281  $ 10,265,018  $    165,241
                     ============  ============  ============  ============

Net income per
 common share, basic $       0.02  $       0.03  $       0.44  $       0.01
                     ============  ============  ============  ============

Net income per
 common share,
 diluted             $       0.02  $       0.03  $       0.39  $       0.01
                     ============  ============  ============  ============

Weighted average
 number of common
 shares outstanding,
 basic                 24,238,613    20,958,877    23,664,723    19,249,783

                     ============  ============  ============  ============
Weighted average
 number of common
 shares outstanding,
 diluted               27,751,946    22,992,211    26,998,057    21,583,117
                     ============  ============  ============  ============


                   FIRST CHOICE HEALTHCARE SOLUTIONS, INC
              CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                (unaudited)

                                            Nine months ended September 30,
                                                 2016             2015
                                           ---------------  ---------------
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income                                 $    10,491,646  $       165,241
Adjustments to reconcile net income to
 cash (used in) provided by operating
 activities:
Depreciation and amortization                      631,571          558,189
Amortization of financing costs                     15,654           60,507
Bad debt expense                                   849,037           51,485
Gain on sale of property                        (9,212,346)               -
Common stock issued in connection with
 loan extension                                          -          227,000
Note payable issued in settlement of
 litigation                                              -           50,749
Stock-based compensation                           668,591          859,991
Changes in operating assets and
 liabilities:
Accounts receivable                             (3,702,212)      (1,678,545)
Prepaid expenses and other                        (129,948)         203,699
Restricted funds                                   359,414          (77,378)
Employee loans                                    (110,716)         (19,728)
Accounts payable and accrued expenses           (1,718,516)         140,254
Settlement payable                                (600,000)               -
Deposits                                           (25,502)          (5,469)
Deferred rent                                      230,671           39,603
Unearned income                                        946            3,941
                                           ---------------  ---------------
  Net cash (used in) provided by operating
   activities                                   (2,251,710)         579,539

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash from variable interest entity                       -          679,673
Proceeds from sale of property                  15,113,497                -
Payment of acquisition deposit                           -         (141,352)
Purchase of equipment                             (239,418)         (92,609)
                                           ---------------  ---------------
  Net cash provided by investing
   activities                                   14,874,079          445,712

CASH FLOWS FROM FINANCING ACTIVITIES:
(Repayments) proceeds from advances                (43,082)         431,406
Payments on lines of credit                        372,636         (331,162)
Net payments on notes payable                   (7,955,886)        (653,023)
                                           ---------------  ---------------
  Net cash used in financing activities         (7,626,332)        (552,779)

Net increase in cash and cash equivalents        4,996,037          472,472
Cash and cash equivalents, beginning of
 period                                          1,594,998          279,087
                                           ---------------  ---------------

Cash and cash equivalents, end of period   $     6,591,035  $       751,559
                                           ===============  ===============

SUPPLEMENTAL DISCLOSURES OF CASH FLOW
 INFORMATION:
Cash paid during the period for interest   $       288,748  $       925,045
                                           ===============  ===============
Cash paid during the period for taxes      $             -  $             -
                                           ===============  ===============

Supplemental Disclosure on non-cash
 investing and financing activities:
Common stock issued in settlement of
 accrued expenses                          $       481,900  $        15,000
                                           ===============  ===============
Common stock issued for future services    $             -  $     1,153,777
                                           ===============  ===============
Common stock issued in settlement of
 related party advances                    $             -  $       655,407
                                           ===============  ===============
Common stock issued in settlement of
 convertible note and interest             $             -  $     2,236,907
                                           ===============  ===============
Fair value of options issued to acquire
 management control of variable interest
 entity                                    $             -  $     3,226,427
                                           ===============  ===============


                   FIRST CHOICE HEATLHCARE SOLUTIONS, INC.
           RECONCILIATION OF NON-GAAP ADJUSTED EBITDA PERFORMANCE
                                 (Unaudited)

                            Three Months Ended         Nine Months Ended
                              September 30,              September 30,
                            2016         2015         2016          2015
                        --------------------------------------  ------------
Net Income Attributable
 to FCHS                $    544,940 $    631,281 $ 10,265,018  $    165,241
Gain on sale of
 property and
 improvements                      -            -   (9,212,346)            -
Depreciation and
 amortization                195,822      273,263      631,571       558,189
Amortization of
 financing costs                   -       20,592       15,654        60,507
Bad debt expense             319,319            -      849,037        51,485
Stock-based
 compensation                322,158      720,241      720,174       859,991
Interest expense, net         56,560      202,907      288,748       925,045
                        --------------------------------------  ------------
Adjusted EBITDA         $  1,438,799 $  1,848,284 $  3,557,856  $  2,620,458


About First Choice Healthcare Solutions, Inc. Headquartered in Melbourne, Florida, First Choice Healthcare Solutions (FCHS) is implementing a defined growth strategy aimed at expanding its network of non-physician-owned medical centers of excellence, which concentrate on treating patients in the following specialties: Orthopaedics, Spine Surgery, Neurology, Interventional Pain Management and related diagnostic and ancillary services in key expansion markets throughout the Southeastern U.S. Serving Florida's Space Coast, the Company's flagship integrated platform currently administers over 100,000 patient visits each year and is comprised of First Choice Medical Group, The B.A.C.K. Center and Crane Creek Surgery Center. For more information, please visit www.myfchs.com, www.myfcmg.com, www.thebackcenter.net and www.cranecreeksurgerycenter.com.

Safe Harbor Statement Certain information set forth in this news announcement may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of First Choice Healthcare Solutions, Inc. Such forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management beliefs and certain assumptions made by its management. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Information concerning factors that could cause the Company's actual results to differ materially from those contained in these forward-looking statements can be found in the Company's periodic reports on Form 10-K and Form 10-Q, and in its Current Reports on Form 8-K, filed with the Securities and Exchange Commission. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise to reflect future events or circumstances or reflect the occurrence of unanticipated events.

Investor Contact:
Wolfe Axelrod Weinberger Associates
Donald C. Weinberger
[email protected]
Stephen D. Axelrod, CFA
[email protected]
Phone: 212-370-4505

At First Choice Healthcare Solutions, Inc.
Phone: 321-802-5830
Email: [email protected]

Source: First Choice Healthcare Solutions, Inc.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Earnings, Definitive Agreement